NBX-100

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameNBX-100
Drug Alias NameNBX-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitors
TargetsMonoamine oxidase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurala Biosciences Pty Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A